CRIS Current Research Information System

NALDI, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.263
AS - Asia 6.947
EU - Europa 5.284
AF - Africa 417
SA - Sud America 332
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 6
Totale 20.267
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.155
SG - Singapore 1.914
CN - Cina 1.749
VN - Vietnam 1.747
IT - Italia 1.159
GB - Regno Unito 1.120
DE - Germania 650
SE - Svezia 539
HK - Hong Kong 455
IN - India 385
FR - Francia 361
RU - Federazione Russa 270
UA - Ucraina 258
BR - Brasile 223
IE - Irlanda 180
KR - Corea 155
NL - Olanda 134
CI - Costa d'Avorio 128
ZA - Sudafrica 116
FI - Finlandia 110
JP - Giappone 110
EE - Estonia 81
CH - Svizzera 76
CA - Canada 63
TG - Togo 63
BG - Bulgaria 62
SC - Seychelles 58
TR - Turchia 50
ES - Italia 49
ID - Indonesia 46
PH - Filippine 46
AR - Argentina 43
BD - Bangladesh 40
IR - Iran 38
TH - Thailandia 38
JO - Giordania 36
BE - Belgio 35
MX - Messico 35
PL - Polonia 35
AT - Austria 32
GR - Grecia 29
TW - Taiwan 28
EC - Ecuador 25
IQ - Iraq 25
PK - Pakistan 21
PT - Portogallo 17
CZ - Repubblica Ceca 16
CL - Cile 14
HR - Croazia 14
SA - Arabia Saudita 14
NG - Nigeria 13
DK - Danimarca 12
MY - Malesia 12
AU - Australia 10
TN - Tunisia 9
UZ - Uzbekistan 9
PY - Paraguay 8
RO - Romania 8
SI - Slovenia 8
CO - Colombia 7
DZ - Algeria 7
EU - Europa 6
MA - Marocco 6
NZ - Nuova Zelanda 6
AE - Emirati Arabi Uniti 5
LT - Lituania 5
NP - Nepal 5
EG - Egitto 4
IL - Israele 4
LB - Libano 4
UY - Uruguay 4
VE - Venezuela 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
ET - Etiopia 3
HU - Ungheria 3
KZ - Kazakistan 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AZ - Azerbaigian 2
CM - Camerun 2
DO - Repubblica Dominicana 2
GI - Gibilterra 2
HN - Honduras 2
MK - Macedonia 2
NC - Nuova Caledonia 2
NO - Norvegia 2
RS - Serbia 2
SM - San Marino 2
SN - Senegal 2
UG - Uganda 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BN - Brunei Darussalam 1
BW - Botswana 1
CR - Costa Rica 1
GD - Grenada 1
GH - Ghana 1
JM - Giamaica 1
Totale 20.258
Salva come PNG Salva come JPEG
Città #
Singapore 1.374
Ashburn 1.135
Southend 948
Chandler 610
Fairfield 468
Hong Kong 433
Dong Ket 374
Ho Chi Minh City 344
San Jose 342
Bologna 337
Santa Clara 337
Hanoi 282
Wilmington 253
Houston 250
Princeton 230
Woodbridge 225
Hefei 218
Beijing 195
Seattle 192
Cambridge 181
Dublin 180
Ann Arbor 171
Jacksonville 166
Boardman 154
Abidjan 128
Dallas 127
Seoul 106
Lauterbourg 104
Westminster 99
Los Angeles 93
Berlin 90
Tokyo 90
Milan 87
Nanjing 86
Helsinki 84
Council Bluffs 83
Padova 79
New York 71
Jinan 63
Lomé 63
Shenyang 62
Sofia 61
Medford 58
Bern 57
Guangzhou 57
Turin 55
Buffalo 54
Munich 49
Da Nang 46
Hebei 46
Changsha 45
Haiphong 44
Saint Petersburg 44
San Diego 43
Shanghai 43
Redmond 42
Redondo Beach 41
Falls Church 40
Frankfurt am Main 38
Tianjin 37
Amman 36
Redwood City 36
São Paulo 35
Des Moines 34
Brussels 33
Bengaluru 30
Chicago 29
Jakarta 29
Mülheim 29
Paris 28
Nanchang 27
London 26
Bremen 25
Dearborn 25
Johannesburg 25
Hangzhou 24
Rome 23
Jiaxing 22
Yubileyny 22
Amsterdam 21
Zhengzhou 21
Chennai 20
Nuremberg 20
Ottawa 20
Falkenstein 19
Lappeenranta 19
Orem 19
Phoenix 18
Istanbul 17
Montreal 17
Barcelona 16
Hyderabad 16
Mahé 16
Shenzhen 16
Vienna 16
Warsaw 16
Atlanta 15
Brooklyn 15
Hải Dương 15
The Dalles 15
Totale 12.719
Salva come PNG Salva come JPEG
Nome #
Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer. 537
STABILITY OF ASCORBIC ACID IN COSMETIC FORMULATION: PROTECTIVE ROLE OF RESVERATROL AND MELATONIN 382
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment 325
Advanced analytical methodologies in Alzheimer's disease drug discovery 290
Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease 273
New insights into the altered binding capacity of pharmaceutical-grade human serum albumin: site-specific binding studies by induced circular dichroism spectroscopy 251
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo 248
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 246
Climate change effects on bread wheat phenology and grain quality: A case study in the north of Italy 238
Antitumoral Efficacy of Two Turmeric Extracts According to Different Extraction Methods in Hepatocellular Carcinoma Cell Lines 236
Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy. 232
Antioxidant and cytoprotective effects of a wheat-derived non specific lipid transfer protein 2 (nsLTP2) on vascular endothelial cells 229
Indole derivative interacts with estrogen receptor beta and inhibits human ovarian cancer cell growth 227
Synthesis, cytotoxicity and anti-cancer activity of new alkynyl-gold(I) complexes 226
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 221
Structural basis for the magnesium-dependent activation of transketolase from Chlamydomonas reinhardtii 220
ANTIPROLIFERATIVE ACTIVITY OF ENANTIOMERICALLY PURE (R) AND (S)-9-HYDROXYSTEARIC ACID IN HT29 COLON CANCER CELLS. 217
Exploiting the chalcone scaffold to develop multifunctional agents for Alzheimer’s disease 209
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus 208
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3 206
Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms 206
9-Hydroxystearic acid and sulforaphane: two natural HDAC inhibitors with distinct effects on HT29 cells. 206
In vitro thrombogenicity of drug-eluting and bare metal stents 200
Analysis of human histone H4 by capillary electrophoresis in a pullulan-coated capillary, LC-ESI-MS and MALDI-TOF-MS 198
Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties 198
Isolation and Characterization of Wheat Derived Nonspecific Lipid Transfer Protein 2 (nsLTP2) 196
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 193
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. 192
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 190
Immobilized Enzyme Reactors: an Overview of Applications in Drug Discovery from 2008 to 2018 188
Redox-sensitive structural features of transketolase from Chlamydomonas reinhardtii (CrTK) 187
ON-LINE GLYCAN RELEASE AND ANALYSIS BY AN INTEGRATED PNGASE F-IMER LC-ESI-Q-TOF APPROACH 186
Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. 185
Unveiling the Biochemistry of the Epigenetic Regulator SMYD3 182
AFM study of F-actin on chemically modified surfaces 181
Posttranscriptional changes of serum albumin: clinical and prognostic meaning in hospitalized patients with cirrhosis. 180
CE Analysis of Basic Proteins and H4 Human Histones using a Pullulan-Coated Capillary 175
Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase 175
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance 174
HS-SPME-GC-MS for the quantitation and chiral characterization of camphor and menthol in creams 174
Inhibition of β-Amyloid Aggregation in Alzheimer's Disease: The Key Role of (Pro)electrophilic Warheads 173
AFM study of F-actin on chemically modified surfaces 172
From combinations to single-molecule polypharmacology—cromolyn-ibuprofen conjugates for alzheimer’s disease 171
ALZHEIMER'S DISEASE DRUG DISCOVERY: NEW ANALYTICAL APPROACHES FOR LEAD SELECTION AND OPTIMIZATION PBA 2009 (20h International Symposium on Pharmaceutical and Biomedical Analysis), Agra, India 01-04 Marzo 2009 170
New Coumarin derivatives as cholinergic and cannabinoid system modulators 170
A MULTI-METHODOLOGICAL APPROACH FOR BETA-AMYLOID AGGREGATION AND INHIBITION STUDIES 168
Amyloid beta-Peptide 25-35 Self Assembly and Its Inhibition: A Model Undecapeptide System to Gain Atomistic and Secondary Structure Details of the Alzheimer's Disease Process and Treatment 168
GA‐RAGE – Effetti dell’albumina glicata plasmatica sulla stimolazione di RAGE nel diabete mellito di tipo 2 con complicanze renali 167
Immobilized enzyme-based analytical tools in the -omics era: recent advances 166
Simple and rapid LC-MS method for the determination of circulating albumin microheterogeneity in veal calves exposed to heat stress 164
Investigating in vitro amyloid peptide 1−42 aggregation: Impact of higher molecular weight stable adducts 163
Rapid MALDI-TOF-MS analysis in the study of interaction between whole bacterial cells and human target molecules: binding of Bifidobacterium to human plasminogen 162
Acetylcholinesterase oriented immobilization on nanopatterned bilayered surfaces for biosensing devices 162
Cell cycle arrest induced by sulforaphane in human colon carcinoma cells HT29 is associated with the hyperacetylation of histone H4. 162
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. 161
BIOLOGICAL EFFECTS OF A NEW CLASS I HDAC SELECTIVE INHIBITOR IN HT29 COLON CANCER CELLS. 159
Role of D(-)-Lactic Acid in Prevention of Chlamydia trachomatis Infection in an In Vitro Model of HeLa Cells 157
IDENTIFICATION OF HISTONE MODIFICATIONS INVOLVED IN HDAC1 INHIBITION BY 9-HSA 157
Development and characterization of beta-secretase monolithic micro-immobilized enzyme reactor for on-line high-performance liquid chromatography studies 155
HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy–an in vitro exploration 154
HEADSPACE SOLID-PHASE MICROEXTRACTION GAS CHROMATOGRAPHY-MASS SPECTROMETRY (HS SPME-GC-MS) DETERMINATION OF ODORANTS IN GREEN TEA 154
Structural characterization of p53 isoforms due to the polymorphism at codon 72 by Mass Spectrometry and Circular Dichroism. 154
Analytical approaches in Alzheimer’s disease Drug Discovery 154
IMMOBILIZED ENZYMES AS TOOLS IN DRUG DISCOVERY 152
Headspace solid-phase microextraction gas chromatography-mass spectrometry (HS SPME-GC-MS) determination of odorants in green tea 152
Towards automation in protein digestion: Development of a monolithic trypsin immobilized reactor for highly efficient on-line digestion and analysis 151
AMYLOID-b-PEPTIDE SELF ASSEMBLY KINETICS BY AFM AND MALDI-TOF MASS SPECTROMETRY 149
Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors 148
EPITOPE IDENTIFICATION OF GLYCATED HSA AND THE EXTRACELLULAR REGION OF HUMAN RAGE BY SPR AND AFFINITY-MS SPECTROMETRY 148
A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017 147
UHPLC determination of catechins for the quality control of green tea 144
Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry 144
Fluorescence biosensing micropatterned surfaces based on immobilized human acetylcholinesterase 144
Polycyclic Maleimide-based Scaffold as New Privileged Structure for Navigating the Cannabinoid System Opportunities 143
From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects 143
ANALYTICAL STRATEGIES FOR THE CHARACTERIZATION OF PROTEIN AGGREGATION AND INHIBITION IN HUMAN DISEASES 142
Interaction between commercial glycated HSA and the extracellular region of human RAGE: a SPR-based study 142
The cell cycle arrest induced by sulforaphane in human colon carcinoma cells HT29 is associated with the hyperacetylation of histone H4. 141
Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors 140
IDENTIFICATION OF HISTONE MODIFICATIONS INVOLVED IN HDACs INHIBITION BY SUBEROYLANILIDE HYDROXAMIC ACID. 139
HISTONE POST-TRANSLATIONAL MODIFICATIONS BY HPLC-ESI-MS AFTER HT29 CELL TREATMENT WITH HDACS INHIBITORS. 139
HPLC determination of β-secretase activity on monolithic CIM disks 135
null 135
HISTONE POST-TRANSLATIONAL MODIFICATIONS DETERMINED BY HIGH-PRESSURE LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY 134
Evidence of class I HDACs inhibition and cell cycle block in human carcinoma cells after (R) or (S)-9- HSA treatment 134
Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach. 133
Histones post-translational modifications in colon cancer cell line determined by HPLC-ESI-MS and Maldi-Tof for the characterization of deacetylase inhibitors 131
- Application of an ESI-MS method enabling the discovery of new non-ATP competitive GSK-3beta inhibitors. 131
PROTEIN GLYCOSILATION ANALYSIS BY AN INTEGRATED PNGASE-F-IMER-LC-ESI-Q-TOF APPROACH 130
Multiwell fluorometric and colorimetric microassays for the evaluation of beta-secretase (BACE-1) inhibitors. 130
Hystones’ isoforms determined by HPLC-MS 129
RAGE IN DIABETES MELLITUS: A MULTIMETHODOLOGICAL STRATEGY TO STUDY GLYCATED HSA-RAGE INTERACTION 128
Application of an ESI-MS method enabling the discovery of new non-ATP competitive GSK-3beta inhibitors. 127
Development of Beta-secretase monolithic micro-imer (immobilized enzyme reactor) for on-line HPLC studies 125
The role of Chromatography in Alzheimer’s Disease Drug Discovery. 125
Application of ESI-MS method for detailed characterization of GSK-3β inhibitors by monitoring GSM peptide phosphorylation.Angelini Farmaceutici. 125
Mass Spectrometry as efficient tool for the characterization of amyloid peptide 25-35 self-assembly species in aggregation and inhibition studies 124
A multi-methodological approach for the investigation of β-Amyloid-CORMs interaction: an LC-ESI/MS and Circular Dichroism study. 124
ACETYLCHOLINESTERASE-BASED ANALYTICAL TOOLS FOR DRUG SCREENING 123
Application of an ESI-QTOF method for the detailed characterization of GSK-3β inhibitors 123
Totale 17.784
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.354
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.354
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021758 0 0 0 0 0 0 0 0 0 89 99 570
2021/20222.278 257 85 93 124 213 128 67 198 114 177 422 400
2022/20232.561 225 315 157 330 195 210 61 186 398 110 190 184
2023/20241.321 59 125 66 86 72 154 235 307 43 59 86 29
2024/20252.960 145 432 305 217 488 160 211 108 55 178 135 526
2025/20266.381 499 721 636 475 757 460 826 232 1.296 479 0 0
Totale 20.704